Position in JNJ
as of Mar 31, 2026
· filed Apr 9, 2026
Position Value
$1,332,442
+$225,674 QoQ
Shares Held
5,451
+1.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026TruWealth Advisors, LLC holds $85,956,222 across 7 Drug Manufacturers - General names. JNJ ranks #5 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
35,900 | $33,019,743 | |
| 2 | ABBV |
AbbVie Inc.
|
90,190 | $19,615,423 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
257,538 | $15,619,679 | |
| 4 | GSK |
GSK plc
|
269,102 | $14,851,739 | |
| 5 | JNJ |
Johnson & Johnson
This page
|
5,451 | $1,332,442 | |
| 6 | PFE |
Pfizer Inc
|
36,369 | $1,021,241 | |
| 7 | MRK |
Merck & Co., Inc.
|
4,123 | $495,955 |
All Filings in JNJ
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,332,442 | 5,451 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $1,106,768 | 5,348 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $995,890 | 5,371 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $779,025 | 5,100 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $833,014 | 5,023 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $817,392 | 5,652 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $889,871 | 5,491 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $783,709 | 5,362 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $949,298 | 6,001 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $18,444,849 | 117,678 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $17,924,021 | 115,082 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $16,969,275 | 102,521 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $15,690,960 | 101,232 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $16,937,202 | 95,880 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $11,583,694 | 70,909 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $12,205,942 | 68,762 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $10,670,132 | 60,205 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $10,655,094 | 62,285 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $9,546,426 | 59,111 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $9,423,786 | 57,204 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $8,919,438 | 54,271 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $8,115,614 | 51,567 | Shares | Sole | 2021-01-26 | |
| No filing history on record for this holder in this stock. | ||||||